ChanTest Opens New Laboratory Facilities for Expanded Cell and Molecular Biology Services

ChanTest Corp.

ChanTest Opens New Laboratory Facilities for Expanded Cell and Molecular Biology Services

PR55930

CLEVELAND, Mar. 4, 2014/PRN=KYODO JBN/--

   ChanTest Corporation, a contract research organization (CRO) that supports

drug safety and discovery research, has enlarged its capacity for providing

cellular and molecular services and reagents.  At the ChanTest headquarters in

Cleveland, OH, the company has expanded its physical footprint by more than 50%.

   Top notch cell and molecular biology remain a priority for ChanTest, "The

Ion Channel Expert." The laboratory expansion reflects the importance of

providing high quality cell lines and cellular reagents for drug research.  

ChanTest scientists use the cells grown in the new facility for ion channel

services and products, and for external clients outsourcing cell and molecular

work to ChanTest.  Examples include standard cell culture services and highly

technical custom cell line development projects.

   ChanTest's Director of Cell & Molecular Biology, Luke Armstrong, Ph.D., sees

the expansion as an important step for continued growth at ChanTest.  "Our cell

and molecular biology service business nearly doubled in 2013 and we expect

another year of strong growth in 2014," said Dr. Armstrong.  "The expansion

helps ChanTest keep up with the growing needs of our clients."

   Founder, President and CEO of ChanTest, Arthur "Buzz" Brown, M.D., Ph.D.

added, "ChanTest offers the highest quality services and reagents in drug

safety and discovery research related to ion channels.  Expanding into the new

facility at the end of 2013 helps ChanTest keep up this long standing culture

of quality."

   The new space at ChanTest is fully operational and used for the following:

    -- State-of-the-art cell culture labs

    -- Capacity for adherent cell scale-up of 10 billion cells

    -- Controlled rate freezer capable of cryopreserving 600 vials of cells

    -- Capability for membrane preparations of up to 2 grams of protein

    -- Large-scale electroporator capable of generating 3 billion transfected

       cells

    -- Flow sorter (FACSAria(TM))

    -- Dedicated molecular biology lab

    -- Radioisotope lab (completion in March 2014)

   About ChanTest(R) - The Ion Channel Expert

   ChanTest has developed the world's most complete library of validated human

ion channel-expressing cell lines to serve all the ion channel needs of its

pharmaceutical and biotech customers. Services range from early functional

screens for profiling drug candidates or ranking within profiles during the

drug-discovery process - to a complete set of in vitro GLP service products for

cardiac risk assessment. ChanTest works in partnership with customers to speed

up the drug development process, to save time and money, and ultimately - to

help make better, safer drugs.

   Visit: http://www.chantest.com to learn more about what we do.

   ChanTest Contact:

   Chris Mathes, Ph.D., M.B.A.

   Chief Commercial Officer

   +1-216-584-0522

   cmathes@chantest.com

   SOURCE: ChanTest Corp.

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中